Multimodality imaging in patients with heart failure and preserved ejection fraction: an expert consensus document of the European Association of Cardiovascular Imaging.


Journal

European heart journal. Cardiovascular Imaging
ISSN: 2047-2412
Titre abrégé: Eur Heart J Cardiovasc Imaging
Pays: England
ID NLM: 101573788

Informations de publication

Date de publication:
24 01 2022
Historique:
received: 23 07 2021
accepted: 10 08 2021
pubmed: 4 11 2021
medline: 17 3 2022
entrez: 3 11 2021
Statut: ppublish

Résumé

Nearly half of all patients with heart failure (HF) have a normal left ventricular (LV) ejection fraction (EF) and the condition is termed heart failure with preserved ejection fraction (HFpEF). It is assumed that in these patients HF is due primarily to LV diastolic dysfunction. The prognosis in HFpEF is almost as severe as in HF with reduced EF (HFrEF). In contrast to HFrEF where drugs and devices are proven to reduce mortality, in HFpEF there has been limited therapy available with documented effects on prognosis. This may reflect that HFpEF encompasses a wide range of different pathological processes, which multimodality imaging is well placed to differentiate. Progress in developing therapies for HFpEF has been hampered by a lack of uniform diagnostic criteria. The present expert consensus document from the European Association of Cardiovascular Imaging (EACVI) provides recommendations regarding how to determine elevated LV filling pressure in the setting of suspected HFpEF and how to use multimodality imaging to determine specific aetiologies in patients with HFpEF.

Identifiants

pubmed: 34729586
pii: 6419840
doi: 10.1093/ehjci/jeab154
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e34-e61

Subventions

Organisme : British Heart Foundation
ID : FS/14/78/31020
Pays : United Kingdom

Investigateurs

Philippe B Bertrand (PB)
Marc Dweck (M)
Kristina H Haugaa (KH)
Leyla Elif Sade (LE)
Ivan Stankovic (I)
Jong-Won Ha (JW)
Sherif Nagueh (S)
Jae K Oh (JK)
Nobuyuki Ohte (N)
Bernard Cosyns (B)

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.

Auteurs

Otto A Smiseth (OA)

Department of Cardiology, Oslo University Hospital, Rikshospitalet, Sognsvannsveien 20, Oslo, Norway.
Institute for Surgical Research, Oslo University Hospital, Rikshospitalet, Sognsvannsveien 20, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Daniel A Morris (DA)

Department of Internal Medicine and Cardiology, Campus Virchow Klinikum, Charité Universitätsmedizin Berlin, Berlin, Germany.

Nuno Cardim (N)

Cardiology Department, Hospital da Luz, Av. Lusíada, N° 100, Lisbon, Portugal.

Maja Cikes (M)

Department of Cardiovascular Diseases, University of Zagreb School of Medicine and University Hospital Center Zagreb, Zagreb, Croatia.

Victoria Delgado (V)

Department of Cardiology, Leiden University Medical Centre, Albinusdreef 2, Leiden 2300 RC, The Netherlands.

Erwan Donal (E)

Service de Cardiologie Et Maladies Vasculaires Et CIC-IT 1414, CHU Rennes, 35000 Rennes, France.
Université de Rennes 1, LTSI, 35000 Rennes, France.

Frank A Flachskampf (FA)

Department of Medical Sciences, Clinical Physiology and Cardiology, Uppsala University Hospital, Uppsala, Sweden.

Maurizio Galderisi (M)

Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy.

Bernhard L Gerber (BL)

Division of Cardiology, Department of Cardiovascular Diseases, Cliniques Universitaires St. Luc, Pôle de Recherche Cardiovasculaire (CARD), Institut de Recherche Expérimentale et Clinique (IREC), Université Catholique de Louvain, Av Hippocrate, 10/2806 Brussels, Belgium.

Alessia Gimelli (A)

Fondazione Toscana Gabriele Monasterio, Via Moruzzi, 1, Pisa 56124, Italy.

Allan L Klein (AL)

Section of Cardiovascular Imaging, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, USA.

Juhani Knuuti (J)

Turku PET Centre, University of Turku, and Turku University Hospital, Turku, Finland.

Patrizio Lancellotti (P)

Department of Cardiology, University of Liège Hospital, Domaine Universitaire du Sart Tilman, Liège B4000, Belgium.
Gruppo Villa Maria Care and Research, Maria Cecilia Hospital, Cotignola, and Anthea Hospital, Bari, Italy.

Julia Mascherbauer (J)

Department of Internal Medicine 3, Karl Landsteiner University of Health Sciences, University Hospital St. Pölten, Krems, Austria.

Davor Milicic (D)

Department of Cardiovascular Diseases, University of Zagreb School of Medicine and University Hospital Center Zagreb, Zagreb, Croatia.

Petar Seferovic (P)

Department of Cardiology, Clinical Center of Serbia, Belgrade, Serbia.
Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

Scott Solomon (S)

Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA.

Thor Edvardsen (T)

Department of Cardiology, Oslo University Hospital, Rikshospitalet, Sognsvannsveien 20, Oslo, Norway.
Institute for Surgical Research, Oslo University Hospital, Rikshospitalet, Sognsvannsveien 20, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Bogdan A Popescu (BA)

Department of Cardiology, University of Medicine and Pharmacy "Carol Davila", Euroecolab, Emergency Institute for Cardiovascular Diseases "Prof. Dr. C. C. Iliescu", Sos. Fundeni 258, sector 2, 022328 Bucharest, Romania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH